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Objectives: Although previous studies have shown increased mortality in renal dysfunction patients
undergoing cardiac surgery, there is lack of data on the pattern of postoperative complications that occur
in such patients and their distribution among dialysis and non-dialysis dependent renal dysfunction.
Methods: This is a retrospective review of prospectively collected data over 8 year period of cardiac
surgery patients. Our cohort consisted of 3598 consecutive patients divided into: normal kidneys
(n ¼ 3276, 91%), renal dysfunction (n ¼ 277, 8%) and dialysis (n ¼ 45, 1%). Postoperative complications
and mortality were analysed. Multivariate analysis was conducted to adjust for the potential confounders
in the association between renal dysfunction and postoperative complications.
Results: Univariate analysis showed increased risk of the following complications among renal dysfunction
and dialysis patients: low cardiac output, arrhythmias, reoperation, prolonged ventilation, readmission to
intensive care, blood transfusion and prolongedhospital stay.Mortality ratewas highest in dialysis patients
compared to renal dysfunction and normal kidney patients (11% vs. 7% vs. 3%, respectively p-value<0.001).
Multivariate analysis showed that renal dysfunctionwith orwithout dialysis is an independent predictor of
postoperative low cardiac output, blood transfusion, prolonged ventilation, and mortality. The odd ratios
were higher for dialysis than non-dialysis dependent patients. This effect persisted after adjusting for
potential confounders such as age and gender.
Conclusion: The presence of renal dysfunction preoperatively increases the rate of postoperative compli-
cations and mortality following cardiac surgery. Prior knowledge of these complications can help in
developing preventative strategies to reduce the associated risk.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Approximately 30% of new hemodialysis patients experience
myocardial infarction within 5 years.1,2 Previous studies have shown
increasedmortality inpatientswith renal dysfunction3 and indialysis
patients4 undergoing cardiac surgery. This could be related to the
renal dysfunction part or could be related to the postoperative
complications that these patients might develop following cardiac
surgery. Prior knowledge of these complications might aid in
reducing the increased mortality observed in such cases leading to
better preventative strategies in the preoperative setting. We sought
to assess the pattern of postoperative complications observed intal Code: 46308, Kuwait. Tel.:
af).
ciates Ltd. Published by Elsevier Ltpatients with renal dysfunction (both dialysis and non-dialysis
dependant) as little is currently known on the pattern of post-
operative complications observed in such patients. In addition, all
previously reported studies only examined one subtype of surgery
whethervalve alone5,6 or coronaryarterybypass graft (CABG)alone1,2
with only limited studies examining the outcome in a combined
procedure.3
2. Patients and methods
2.1. Patients
This is a retrospective review of a prospectively collected database (Patient Anal-
ysis and Tracking System, Dendrite Clinical, UK). All patients who underwent CABG,
valve surgery or combination of both in the department of cardiothoracic surgery at St
James hospital between the period of January 2000 and July 2008 were reviewed. A
total of 3598 consecutive patients were included in the study. Patients were divided
into three groups: normal kidney (n¼ 3276, 91%), renal dysfunction (n¼ 277, 8%) and
dialysis group (n¼ 45,1%). Patientswithhistoryof renal transplantationwere excludedd. All rights reserved.
Table 1
Patients demographics and admission characteristics of all patients examined
(n ¼ 3598).
Variable Normal
kidneys
(n ¼ 3276)
Renal
dysfunction
(n ¼ 277)
Dialysis
(n ¼ 45)
p-value
Age (years)
Mean  SD 63.2  10.1 69.5  8.4 62  12.3 <0.001a
Gender
Female 829 (25%) 59 (21%) 10 (22%)
Male 2447 (75%) 218 (79%) 35 (78%) 0.306
Creatinine level (mmol/L)
Mean  SD 92.3  14.9 141.8  17.7 490.7  317.5 <0.001a
Euro SCORE
Mean  SD 3.9  2.9 5.5  3.1 6.8  3.8 <0.001a
Angina class (CCS)
0e2 1589 (49%) 126 (45%) 25 (56%)
3e4 1687 (51%) 151 (55%) 20 (44%) 0.391
NYHA score
IeII 1918 (59%) 147 (53%) 26 (58%)
IIIeIV 1358 (41%) 130 (47%) 19 (42%) 0.207
Congestive cardiac failure
Yes 518 (16%) 82 (30%) 17 (38%)
No 2758 (84%) 195 (70%) 28 (62%) <0.001a
Number of MI
None 2038 (62%) 148 (53%) 29 (64%)
One 1017 (31%) 104 (38%) 13 (29%)
Two or more 221 (7%) 25 (9%) 3 (7%) 0.069
Interval of MI to surgery
None 2038 (62%) 148 (53%) 29 (64%)
<90 days 565 (17%) 52 (19%) 8 (18%)
>90 days 673 (21%) 77 (28%) 8 (18%) 0.037a
Active endocarditis
Yes 44 (1%) 7 (3%) 2 (4%)
No 3232 (99%) 270 (97%) 43 (96%) 0.073
Previous PCI
Yes 385 (12%) 33 (12%) 9 (20%)
No 2891 (88%) 244 (88%) 36 (80%) 0.236
Diabetes mellitus
Yes 560 (17%) 51 (18%) 10 (22%)
No 2716 (83%) 226 (82%) 35 (78%) 0.578
Hypercholesterolemia
Yes 2215 (68%) 185 (67%) 31 (69%)
No 1061 (32%) 92 (33%) 14 (31%) 0.944
Hypertension
Yes 1695 (52%) 176 (64%) 34 (76%)
No 1581 (48%) 101 (36%) 11 (24%) <0.001a
Chronic obstructive pulmonary disease
Yes 304 (9%) 20 (7%) 5 (11%)
No 2972 (91%) 257 (93%) 40 (89%) 0.469
Cerebrovascular accident
Yes 170 (5%) 23 (8%) 5 (11%)
No 3106 (95%) 254 (92%) 40 (89%) 0.023a
Peripheral vascular disease
Yes 502 (15%) 50 (18%) 9 (20%)
No 2774 (85%) 227 (82%) 36 (80%) 0.410
Pre-op arrhythmia
Yes 359 (11%) 55 (20%) 6 (13%)
No 2917 (89%) 222 (80%) 39 (87%) <0.001a
Extra-cardiac arteriopathy
Yes 163 (5%) 15 (5%) 8 (18%)
No 3113 (95%) 262 (95%) 37 (82%) 0.001a
Extent of coronary artery disease
Single/double 776 (23%) 54 (20%) 15 (33%)
Triple 1987 (61%) 167 (60%) 21 (27%)
Normal 513 (16%) 56 (20%) 9 (20%) 0.062
Left main disease
Yes 770 (24%) 64 (23%) 7 (16%)
No 2506 (76%) 213 (77%) 38 (84%) 0.454
Ejection fraction (%)
<50% (fair/poor) 1159 (35%) 144 (52%) 27 (60%)
50% (good) 2117 (65%) 133 (48%) 18 (40%) <0.001a
IV nitrates/heparin pre-op
Yes 313 (10%) 30 (11%) 2 (4%)
No 2963 (90%) 247 (89%) 43 (96%) 0.392
Cardiogenic shock pre-op
Yes 49 (2%) 8 (3%) 3 (7%)
No 3227 (98%) 269 (97%) 42 (93%) 0.007a
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>125mmol/L.All datawere collectedprospectively inadepartmental database through
the input of a dedicated database manager. Outcome measures studied included all
types of postoperative complications, in-hospital mortality, blood transfusion and
lengths of both intensive care unit and hospital stay. This study and the departmental
database were both approved by our institutional review board. Individual patient
consent was obtained for entry into the database. However, our institutional review
board waived the need for individual patient consent for this study.
2.2. Cardiopulmonary bypass (CPB) and deﬁnitions
All cardiac surgeries were performed through a median sternotomy with CPB as
previously described.7 Following full anticoagulationwith heparin given at a dose of
300 IU/kg to maintain an activated clotting time of 400e600 s, CPB was instituted
using ascending aortic cannulation and a two-stage right atrial venous cannulation.
A roller pump (jostra HL 20) and hollow-ﬁbre membrane oxygenator (Optima, Cobe
Cardiovascular Inc.) were used. The extracorporeal circuit was primed with 1400 ml
of Hartmann’s solution and 5000 IU heparin. CPBwasmaintainedwith non-pulsatile
ﬂow with a minimum ﬂow rate of 2.4 l/m2/min at normothermia with temperature
allowed to drift to 32 Celsius. Arterial line ﬁltration (Sentoy, Cobe Cardiovascular
Inc.) was used in all cases. Shed blood was recycled using cardiotomy suction. Acid-
base was managedwith alpha stat control. Myocardial protectionwas achievedwith
intermittent antegrade cold/tepid blood cardioplegia. On completion of all distal
anastomoses, the aortic cross-clamp was removed and the proximal anastomoses
performedwith partial aortic clamping. Heparinwas reversed with protamine at 1:1
ratio onweaning off cardiopulmonary bypass. Operative priority was determined by
cardiothoracic surgeons according to standard criteria andwas previously reported.8
In-hospital mortality refers to all deaths within the same admission post cardiac
surgery regardless of their length of stay. Postoperative complications (including
pulmonary, gastrointestinal, infective, neurological) were previously reported in
detail.9,10
2.3. Statistical analysis
Patients’ socio-demographic characteristics and baseline characteristics as well as
postoperative outcome variables were compared between the three groups: normal
kidney, renal dysfunction and dialysis patients, using appropriate bivariate statistical
methods. Mean levels of normal continuous variables between the three groups were
compared using ANOVA or in case of non-normality, Kruskal Wallis test. Categorical
variables between the groups were compared using Chi-square test. Postoperative
outcomes that were identiﬁed to be signiﬁcantly different between the two groups
were subjected to further multivariate logistic regression models to see if the differ-
ences persist after adjusting for age and gender, these being potential confounders for
postoperative complications. Crude and adjusted odds ratios along with P-values and
95% conﬁdence intervals were reported. Statistical analysis was performed using SPSS
version 17 (SPSS, Chicago, Illinois). The p-values were considered statistically signiﬁ-
cant when less than 0.05.
3. Results
Our cohort (n ¼ 3598) consisted of 898 (25%) females and 2700
(75%)males. Age ranged from19 to 89 years oldwith amean (1 SD)
of 63.7 (10.1) years old. In-hospital mortality overall was 3.2% (114
patients). Dialysiswas present in 45 patients overall (1%)while renal
dysfunction not requiring dialysis was present in 277 patients (8%).
Preoperative factors and patient characteristics among the study
groups together with their relevant p-values as determined by
univariate analysis are summarized inTable 1. As shown in this table,
therewereno signiﬁcant differences between the threegroups in the
following variables: gender, angina class, New York Heart Associa-
tion score, number of previous myocardial infarctions, preoperative
active endocarditis, previous percutaneous coronary intervention,
diabetes mellitus, hypercholesterolemia, chronic obstructive
pulmonary disease, peripheral vascular disease, extent of coronary
artery disease, leftmain stemdisease, the use of intravenous nitrates
and heparin preoperatively, intra-aortic balloon pump use preoper-
atively and priority of surgery. Dialysis patients were younger with
higher mean creatinine level and higher Euro SCORE than renal
dysfunction and normal kidney patients (Table 1). Compared to
normal kidneys and renal dysfunction patients, dialysis patients had
signiﬁcantly higher prevalence of congestive cardiac failure, hyper-
tension, cerebrovascular accident, extra-cardiac arteriopathy, poor
ejection fraction (<50%), higher prevalence of cardiogenic shock and
Table 2
Univariate analysis of postoperative complications in normal kidneys, renal
dysfunction and dialysis groups (n ¼ 3598).
Variable Normal
kidneys
(n ¼ 3276)
Renal
dysfunction
(n ¼ 277)
Dialysis
(n ¼ 45)
p-value
Low cardiac output
Inotropes  IABP 1251 (38%) 161 (58%) 30 (67%)
None 2025 (62%) 116 (42%) 15 (33%) <0.001a
Arrhythmias
Yes 1220 (37%) 135 (49%) 21 (47%)
No 2056 (63%) 142 (51%) 24 (53%) <0.001a
Re-operation
Yes 179 (5%) 24 (9%) 5 (11%)
No 3097 (95%) 253 (91%) 40 (89%) 0.028a
Ventilation time
<24 h 3075 (94%) 246 (89%) 37 (82%)
>24 h 201 (6%) 31 (11%) 8 (18%) <0.001a
Pulmonary complications
Yes 449 (14%) 46 (17%) 8 (18%)
No 2827 (86%) 231 (83%) 37 (82%) 0.311
Neurological complications
Yes 62 (2%) 14 (5%) 0
No 3214 (98%) 263 (95%) 45 (100%) 0.001a
Infective complications
Yes 247 (8%) 31 (11%) 4 (9%)
No 3029 (92%) 246 (89%) 41 (91%) 0.091
Gastrointestinal complications
Yes 38 (1%) 5 (2%) 1 (2%)
No 3238 (99%) 272 (98%) 44 (98%) 0.533
Readmission to ICU
Yes 96 (3%) 17 (6%) 4 (9%)
No 3180 (97%) 260 (94%) 41 (91%) 0.002a
ICU stay (days)
Mean  SD 2.2  5.3 3.4  6.4 3.7  4.5 <0.001a
Post-op stay (days)
Mean  SD 8.5  11.0 11.1  12.9 11.2  9.6 <0.001a
Blood transfusion
Yes 1394 (43%) 151 (55%) 37 (82%)
No 1882 (57%) 126 (45%) 8 (18%) <0.001a
Status
Alive 3187 (97%) 257 (93%) 40 (89%)
Dead 89 (3%) 20 (7%) 5 (11%) <0.001a
IABP: intra-aortic balloon pump, ICU: Intensive care unit.
a Statistically signiﬁcant (p-value <0.05).
Table 1 (continued )
Variable Normal
kidneys
(n ¼ 3276)
Renal
dysfunction
(n ¼ 277)
Dialysis
(n ¼ 45)
p-value
Pre-op IABP
Yes 34 (1%) 5 (2%) 1 (2%)
No 3242 (99%) 272 (98%) 44 (98%) 0.391
Priority
Elective/urgent 3155 (96%) 267 (96%) 43 (96%)
Emergent/salvage 121 (4%) 10 (4%) 2 (4%) 0.962
Type of surgery
CABG 2437 (74%) 177 (64%) 29 (64%)
Valve 551 (17%) 57 (20%) 9 (20%)
CAB þ valve 288 (9%) 43 (16%) 7 (16%) <0.001a
Body mass index (kg/m2)
Mean  SD 27.6  4.8 27.7  4.5 25.5  4.4 0.012a
Cardiopulmonary Bypass (minutes)
Mean  SD 99.9  37.4 107.6  39.9 105.7  52.4 0.004a
Aortic cross-clamp time (minutes)
Mean  SD 60.5  26.3 65  27.1 63.7  39.8 0.020a
CABG: coronary artery bypass graft, CCS: Canadian cardiovascular society, IABP:
intra-aortic balloon pump, MI: myocardial infarction, NYHA: New York Heart
Association PCI: percutaneous coronary intervention SD: standard deviation.
a Statistically signiﬁcant (p-value <0.05).
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arrhythmias than normal kidneys but lower than renal dysfunction
patients (13% vs. 11% vs. 20%, respectively, p-value <0.001). Both
renal dysfunctionanddialysispatientsunderwent signiﬁcantlymore
valve surgeries and combined CABG and valve surgeries than normal
kidney patients with less isolated CABG, as such cardiopulmonary
bypass time and aortic cross-clamp time were signiﬁcantly longer
among these two groups compared to normal kidney patients. The
exact percentages and the p-values are summarized in Table 1.
Table 2 is a summary of postoperative complications and in-
hospital mortality among the three groups with their relevant p-
values, as determined by univariate analysis. As shown in this table,
there was no signiﬁcant difference detected in the rates of infective
and gastrointestinal complications. Compared to renal dysfunction
patients and normal kidney patients, dialysis patients had higher
incidence of low output syndrome (67% vs. 58% vs. 38%, respec-
tively, p-value <0.001), more reoperations (11% vs. 9% vs.5%,
respectively, p-value 0.028), prolonged ventilation (18% vs. 11% vs.
6%, respectively, p-value <0.001), higher rate of intensive care unit
(ICU) readmission (9% vs. 6% vs. 3%, respectively, p-value 0.002),
prolonged hospital stay and ICU stay, more blood transfusions (82%
vs. 55% vs. 43%, respectively, p-value<0.001) and higher in-hospital
mortality (11% vs. 7% vs. 3%, respectively, p-value <0.001). Post-
operative arrhythmias were higher in renal dysfunction and dial-
ysis groups compared to normal kidneys patients (47% vs. 49% vs.
37%, respectively, p-value < 0.001). Neurological complications
were signiﬁcantly higher in renal dysfunction group compared to
normal kidneys (5% vs. 2%, p-value 0.001) with no neurological
complications observed in dialysis group.
Multivariate analysis showed that both renal dysfunction and
dialysis were independent predictors of in-hospital mortality, blood
transfusion, low cardiac output and prolonged ventilation when
compared to normal kidney patients with signiﬁcantly higher odd
ratios for dialysis patients than renal dysfunction patients. This
effect persisted after adjusting for potential confounders such as age
and gender. A summary of these results is depicted in Table 3.4. Discussion
Approximately 30% of new hemodialysis patients experience
myocardial infarction within 5 years1,2 and such patients are
increasingly being referred for cardiac surgery intervention. Thechallenges of dealing with such cases remains in reducing the
increased risk of mortality associated with such intervention
compared to normal kidney function patients. Prior knowledge on
the complication pattern that such patients might develop can help
in reducing their complications and therefore reducing the
mortality rate. Both renal dysfunction and dialysis patients are at
increased risk of mortality following cardiac surgery compared to
normal kidney patients. This is due to increased incidence of some
preoperative factors that affect the postoperative mortality such as
congestive cardiac failure, extra-cardiac arteriopathy, cerebrovas-
cular accident, and depressed ejection fraction (as shown in Table
1). Such factors were signiﬁcantly higher among both renal
dysfunctions and dialysis patients. Another reason is the increased
risk of complications observed in these patients such as those
outlined in Table 2. Both renal dysfunction and dialysis patients had
signiﬁcantly higher risk of low cardiac output requiring inotropic
support with or without IABP, higher blood transfusions, prolonged
ventilation, higher incidence of arrhythmias (Table 2). The net
effect was higher mortality in renal dysfunction and dialysis
patients following cardiac surgery. Our observation is consistent
with mortality ﬁgures reported in the literature.3e5
The increasedblood transfusion requirements observed indialysis
and renal dysfunction patients is related to preoperative anaemia in
these patients secondary to low erythropoietin production as
a consequence of renal failure.11 In addition, the rate of exploration
Table 3
Multivariate analysis showing independent association of dialysis and renal dysfunctionwith in-hospital mortality, blood transfusion and low cardiac output. Odds ratios (OR)
are expressed as crude, age adjusted, gender adjusted, and age and gender adjusted.
Renal dysfunction (n ¼ 277) Dialysis (n ¼ 45) Normal kidneys (n ¼ 3276)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI)
Mortality
Crude 2.8 (1.7e4.6) <0.001 4.5 (1.7e11.6) 0.002 Ref.
Adjusted by gender 2.8 (1.7e4.7) <0.001 4.5 (1.7e11.7) 0.002 Ref.
Adjusted by age 2.1 (1.2e3.5) 0.005 4.7 (1.8e12.5) 0.002 Ref.
Adjusted by gender and age 2.1 (1.3e3.5) 0.005 4.8 (1.8e12.5) 0.002 Ref.
Blood transfused
Crude 1.6 (1.3e2.1) <0.001 6.2 (2.9e13.5) <0.001 Ref.
Adjusted by gender 1.7 (1.4e2.3) <0.001 7.0 (3.2e15.3) <0.001 Ref.
Adjusted by age 1.2 (0.9e1.5) 0.246 7.9 (3.5e17.8) <0.001 Ref.
Adjusted by gender and age 1.3 (0.99e1.7) 0.064 8.4 (3.8e18.8) <0.001 Ref.
Low cardiac output
Crude 2.2 (1.8e2.9) <0.001 3.2 (1.7e6.0) <0.001 Ref.
Adjusted by gender 2.3 (1.8e2.9) <0.001 3.3 (1.7e6.1) <0.001 Ref.
Adjusted by age 1.8 (1.4e2.3) <0.001 3.5 (1.9e6.7) <0.001 Ref.
Adjusted by gender and age 1.8 (1.4e2.4) <0.001 3.6 (1.9e6.7) <0.001 Ref.
Prolonged ventilation
Crude 1.9 (1.3e2.9) 0.001 3.3 (1.5e7.2) 0.003 Ref.
Adjusted by gender 2.0 (1.3e2.9) 0.001 3.3 (1.5e7.3) 0.002 Ref.
Adjusted by age 1.5 (1.0e2.3) 0.048 3.5 (1.6e7.7) 0.002 Ref.
Adjusted by gender and age 1.5 (1.0e2.3) 0.040 3.5 (1.6e7.7) 0.002 Ref.
CI: conﬁdence interval.
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higher among renal dysfunction and dialysis patients compared to
normal kidneypatients secondary toplatelet abnormalities.11Dialysis
patients have abnormalities in plateleteplatelet and platelet-vessel
wall interaction secondary to uremic toxins in circulating blood
leading to platelet dysfunction and increased risk of bleeding.11
Dialysis itself can also contribute to the bleeding through the
continuous platelet activation induced by the interaction between
blood and artiﬁcial surfaces and the use of anticoagulants.11 These
factors predispose renal dysfunction patients to increased risk of
bleeding and increased blood transfusion requirements. This agrees
with the reported ﬁgures in the literature where a similar trend was
observed.4
Both dialysis and non-dialysis dependent renal dysfunction
patients have higher incidence of low cardiac output following
cardiac surgery. This is a result of the low ejection fraction and the
increased prevalence of congestive cardiac failure observed in these
patients (Table 1). In addition, dialysis patients are reported to have
abnormalities in the myocardial ultra structure and function
including endothelial dysfunction, interstitial ﬁbrosis and decreased
perfusion reserve12 which can lead to low cardiac output. In our
study, dialysis patients had a 3.6 fold increase in the incidence of low
cardiac output compared to controls while renal dysfunction
patients had a 1.8 fold increase (Table 3).
Dialysis dependent and non-dialysis dependent renal dysfunc-
tion were both associated with increased risk of prolonged venti-
lation (OR 3.5 and 1.5, respectively). This is due to ﬂuid overload
causing lung congestion with poor oxygenation compared to
patients with normal renal function leading to prolonged mechan-
ical ventilation.13 Our observation is consistent with those reported
in the literature.4,13 Massad and colleagues4 reported prolonged
ventilation rate (>24 h) in dialysis patients compared to renal
dysfunction patients. They observed 24% of dialysis patients
requiring prolonged ventilation compared to 10% of renal dysfunc-
tion patients. Prolonged ventilation in addition to other complica-
tions can lead to prolonged ICU and hospital stay. Aswe have shown
in Table 2, renal dysfunction patients (both dialysis and non-dialysis
dependent) had signiﬁcantly longer hospital and ICU stay than
normal kidney patients.
The management of renal dysfunction patients require careful
management of ﬂuid balance, electrolyte imbalances, anaemia, lowplatelet counts andmetabolic acidosis. Various strategies have been
suggested including early reinstitution of hemodialysis, use of
continuous venovenous hemodialysis (CVVHD) in the immediate
postoperative period, use of pulsatile ﬂow intraoperatively, use of
arterial grafts as conduits, off-pump surgery, higher perfusion pres-
sures on pump, use of frusemide, mannitol and dopamine infusion
and adequate ﬁlling.14,15 In addition, close work of intensivist,
anaesthetist, nephrologist and cardiac surgeons in these cases are of
vital importance in themanagement of these patients. Furthermore,
potential recognition of the range of postoperative complications
that might arise in these patients may help in preventing them or
reducing their occurrence.5. Limitations of the study
Although our datawere prospectively collected, the analysis was
done in a retrospective manner and as such we can only report an
association rather than causality. Causality could only be estab-
lished by performing a randomized controlled trial. A second
limitation is the relatively small number of dialysis patients
(n ¼ 45) which was similar to number reported elsewhere in the
literature reﬂecting the low volume of such cases referred to
cardiac surgery. In addition, our database does not collect preop-
erative haemoglobin and platelet levels and as such the association
between these variables to the risk of bleeding and blood trans-
fusion requirement in renal dysfunction patients cannot be inves-
tigated. However, within these acceptable limitations, we believe
our work will shed more light into the subject and potentially
stimulate more studies with larger number of patients.6. Conclusion
Dialysis and non-dialysis dependent renal dysfunction patients
are at increased risk ofmortality following cardiac surgery compared
to normal kidney function patients. The range of postoperative
complications observed in such patients includes prolonged venti-
lation, low cardiac output and increased blood transfusion require-
ments. Prior knowledge of such complications might aid in
preventing some of these complications or reducing their
occurrences.
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